JP2012509313A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509313A5
JP2012509313A5 JP2011537013A JP2011537013A JP2012509313A5 JP 2012509313 A5 JP2012509313 A5 JP 2012509313A5 JP 2011537013 A JP2011537013 A JP 2011537013A JP 2011537013 A JP2011537013 A JP 2011537013A JP 2012509313 A5 JP2012509313 A5 JP 2012509313A5
Authority
JP
Japan
Prior art keywords
alkoxy
heteroaryl
alkyl
aryl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011537013A
Other languages
English (en)
Japanese (ja)
Other versions
JP5662940B2 (ja
JP2012509313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2009/000658 external-priority patent/WO2010058423A2/en
Publication of JP2012509313A publication Critical patent/JP2012509313A/ja
Publication of JP2012509313A5 publication Critical patent/JP2012509313A5/ja
Application granted granted Critical
Publication of JP5662940B2 publication Critical patent/JP5662940B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011537013A 2008-11-20 2009-11-18 新規な抗微生物薬 Expired - Fee Related JP5662940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2623/DEL/2008 2008-11-20
IN2623DE2008 2008-11-20
PCT/IN2009/000658 WO2010058423A2 (en) 2008-11-20 2009-11-18 Novel antimicrobials

Publications (3)

Publication Number Publication Date
JP2012509313A JP2012509313A (ja) 2012-04-19
JP2012509313A5 true JP2012509313A5 (enExample) 2012-12-27
JP5662940B2 JP5662940B2 (ja) 2015-02-04

Family

ID=42198604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011537013A Expired - Fee Related JP5662940B2 (ja) 2008-11-20 2009-11-18 新規な抗微生物薬

Country Status (12)

Country Link
US (1) US8841306B2 (enExample)
EP (1) EP2367820B1 (enExample)
JP (1) JP5662940B2 (enExample)
KR (1) KR20110092309A (enExample)
CN (1) CN102224151A (enExample)
AR (1) AR074387A1 (enExample)
AU (1) AU2009318783A1 (enExample)
CA (1) CA2743971A1 (enExample)
MX (1) MX2011005365A (enExample)
RU (1) RU2522582C2 (enExample)
WO (1) WO2010058423A2 (enExample)
ZA (1) ZA201103978B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2627653B1 (en) 2010-10-13 2014-12-24 Glaxo Group Limited 3-amino-pyrazole derivatives useful against tuberculosis
PT106651A (pt) * 2012-11-20 2014-05-20 Tecnimede Sociedade Tecnico Medicinal S A Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas
CN103450173B (zh) * 2013-09-07 2015-06-03 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途
US10995097B2 (en) * 2016-03-11 2021-05-04 The Board Of Trustees Of The University Of Illinois Small molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
EP4100023A4 (en) * 2020-02-07 2024-03-13 University of South Florida Inhibition of beta-arrestin oligomerization in tauopathy

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119556C (en) 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5646244A (en) 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
FI974180A0 (fi) 1995-05-11 1997-11-10 Upjohn Co Spirosyklisiä ja bisyklisiä diatsinyyli- ja karbatsinyylioksatsolidinoneja
CA2228647A1 (en) 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
SK18362000A3 (sk) 1998-06-05 2001-06-11 Astrazeneca Ab Oxazolidinónové deriváty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
JP2000204084A (ja) 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
WO2000029396A1 (de) 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
BR0010982A (pt) 1999-05-27 2002-03-05 Upjohn Co Novas oxazolidinonas bicìclicas como agentes antibacterianos
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6689779B2 (en) 2000-06-05 2004-02-10 Dong A Pharm. Co., Ltd. Oxazolidinone derivatives and a process for the preparation thereof
ES2245698T3 (es) 2000-06-30 2006-01-16 PHARMACIA & UPJOHN COMPANY LLC Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina.
WO2003008389A1 (en) 2001-07-16 2003-01-30 Ranbaxy Laboratories Limited Oxazolidinone derivatives as potential antimicrobials
DOP2002000333A (es) 2001-02-14 2002-09-30 Warner Lambert Co Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
WO2002081470A1 (en) 2001-04-07 2002-10-17 Astrazeneca Ab Oxazolidinones containing a sulfonimid group as antibiotics
JP2004534097A (ja) 2001-07-09 2004-11-11 フアルマシア・イタリア・エツセ・ピー・アー TCF−4とβ−カテニンの相互作用阻害剤
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
KR20040106551A (ko) 2002-05-15 2004-12-17 랜박시 래보러터리스 리미티드 페닐 옥사졸리디논 유도체의 다형 제제
WO2003097640A1 (en) 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
WO2004009587A1 (en) 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
AU2002319848A1 (en) 2002-07-29 2004-02-25 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
AU2003253141A1 (en) * 2002-08-22 2004-03-11 Orchid Chemicals And Pharmaceuticals Ltd Novel antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
AR042086A1 (es) * 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
CN1237056C (zh) * 2002-12-25 2006-01-18 中国科学院上海药物研究所 噁唑烷酮类化合物、其制备方法和用途
WO2004089944A1 (en) * 2003-04-07 2004-10-21 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
WO2004113329A1 (en) 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
WO2005003087A2 (en) 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
JP2007521284A (ja) 2003-07-02 2007-08-02 メルク アンド カンパニー インコーポレーテッド オキサゾリジノン系抗生物質及びその誘導体
CA2529292A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
US20050118624A1 (en) * 2003-10-03 2005-06-02 Cumbre Inc. Fluorescent probes for ribosomes and method of use
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082897A1 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone antibacterial agents
WO2005082900A2 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
US20080064689A1 (en) 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
JP2008500319A (ja) 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 細菌感染症の治療のためのmao阻害剤としての3−(4−(2−ジヒドロイソオキサゾール−3−イルピリジン−5−イル)フェニル−5−トリアゾール−1−イルメチルオキサゾリジン−2−オン誘導体
WO2006035283A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006043121A1 (en) 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US8067418B2 (en) 2005-04-12 2011-11-29 Vicore Pharma Ab Tricyclic angiotensin II agonists
EP1745784A1 (en) 2005-06-27 2007-01-24 Ferrer Internacional, S.A. Oxazolidinone derivatives and use thereof as antibiotics
CA2614105A1 (en) 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
KR20070038236A (ko) 2005-10-05 2007-04-10 일동제약주식회사 신규 옥사졸리디논 포름 아미드 유도체 및 그 제조방법
CA2637052A1 (en) * 2006-01-19 2007-07-26 Laboratorios Salvat, S.A. Dicarbonylic compounds with antibacterial activity
ES2331930T3 (es) 2006-02-14 2010-01-20 Pfizer Products Inc. Oxazolidinonas con benzoxazinonas y benzoxazepinonas como agentes antibacterianos.
CN100406455C (zh) 2006-02-20 2008-07-30 中国科学院上海药物研究所 含三氮唑基的噁唑烷酮类化合物及其制备方法和用途
US8148362B2 (en) 2006-03-31 2012-04-03 Research Foundation Itsuu Laboratory Compound having heterocyclic ring
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
CN101434584A (zh) * 2007-11-15 2009-05-20 中山大学 具有抗菌活性的手性噁唑烷酮类化合物

Similar Documents

Publication Publication Date Title
JP2013532652A5 (enExample)
JP2012509313A5 (enExample)
JP2018526367A5 (enExample)
JP2007505933A5 (enExample)
JP2014530900A5 (enExample)
JP2016505619A5 (enExample)
JP2015531773A5 (enExample)
JP2019094345A5 (enExample)
JP2014526500A5 (enExample)
JP2017518959A5 (enExample)
JP2012526728A5 (enExample)
JP6261011B2 (ja) 眼疾患処置薬
JP2009535307A5 (enExample)
JP2018535963A5 (enExample)
JP2017517508A5 (enExample)
JP2009527501A5 (enExample)
JP2016534063A5 (enExample)
JP2016510323A5 (enExample)
JP2019522055A5 (enExample)
JP2016506959A5 (enExample)
JP2018513832A5 (enExample)
JP2013542267A5 (enExample)
JP2018109017A5 (enExample)
JP2009543795A5 (enExample)
JP2019531346A5 (enExample)